Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon–mediated fibrosis
Journal of Human Immunity · 04.05.2026 · 2 (3)
DOI: 10.70962/jhi.20250011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 24.02.2026. Verfasst von Christos Sazeides und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genetic Errors of Immunity, Columbia University, New York, NY, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
ISG15 deficiency is a type I interferonopathy characterized by elevated circulating type I interferon (IFN-I), intracranial calcifications, fibrotic skin lesions, and occasionally inflammatory lung disease. However, the mechanisms driving immune-mediated fibrosis remain poorly understood. In this study, we combined molecular biology approaches with spatial transcriptomics in ex vivo patient samples and in vitro models to characterize a novel loss-of-function ISG15 variant and to elucidate disease-associated molecular pathways. Analysis of patient skin biopsies revealed increased IFN-I–dependent apoptosis, altered macrophage polarization, enhanced epithelial-to-mesenchymal transition (EMT), and myofibroblast activation. In vitro, ISG15 knockout (KO), but not wild-type (WT), epithelial cells were predisposed to EMT following combined TGF-β and IFN-I stimulation. Additionally, ISG15 KO fibroblasts displayed impaired mechanical wound healing and increased IFN-I–induced apoptosis compared with WT cells. Collectively, our findings suggest that chronic IFN-I exposure in ISG15 deficiency disrupts wound repair, skews macrophage activation, and promotes EMT, contributing to fibrosis across multiple organ systems.
Autor:innen und Institutionen
- Center for Genetic Errors of Immunity, Columbia University, New York, NY, USA.
- Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
- Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Rare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
ORCID-Profile: Christos Sazeides, Lorenzo Cuollo, Ikjot Sidhu, Haley E Randolph, Marta Martin-Fernandez, Sofija Buta, O' Jay Stewart, Rachel Geltman, Jonas A Adalsteinsson, Robert G Phelps, Amir Horowitz, David Stein, Mariam Youssef, Michelle Hernandez, Michail S Lionakis, Alexis Boneparth, Joshua D Milner, Shruti Naik, Dusan Bogunovic
Förderung
- NIAID NIH HHS
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Sazeides, C., Cuollo, L., Sidhu, I., Randolph, H. E., Martin-Fernandez, M., Buta, S., Stewart, O. J., Geltman, R., Adalsteinsson, J. A., Phelps, R. G., Horowitz, A., Stein, D., Youssef, M., Martinez-Muniz, A., Hernandez, M., Lionakis, M. S., Boneparth, A., Milner, J. D., Naik, S., & Bogunovic, D. (2026). Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon–mediated fibrosis. Journal of Human Immunity, 2(3). https://doi.org/10.70962/jhi.20250011
Vancouver
Sazeides C, Cuollo L, Sidhu I, Randolph HE, Martin-Fernandez M, Buta S, et al. Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon–mediated fibrosis. Journal of Human Immunity. 2026;2(3). doi:10.70962/jhi.20250011
BibTeX
@article{Sazeides2026,
author = {Sazeides, Christos and Cuollo, Lorenzo and Sidhu, Ikjot and Randolph, Haley E and Martin-Fernandez, Marta and Buta, Sofija and Stewart, O' Jay and Geltman, Rachel and Adalsteinsson, Jonas A and Phelps, Robert G and Horowitz, Amir and Stein, David and Youssef, Mariam and Martinez-Muniz, Andres and Hernandez, Michelle and Lionakis, Michail S and Boneparth, Alexis and Milner, Joshua D and Naik, Shruti and Bogunovic, Dusan},
title = {Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon–mediated fibrosis},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {3},
doi = {10.70962/jhi.20250011}
}
EUVIMED